Podcast: Diagnosis and Treatment of Patients With Postconcussion Syndrome

January 16th 2025

Distress Signals: How to Help a Clinician Colleague in Need

The Florey Dementia Index showed robustness across different cohorts but more testing is needed, researchers reported.

February 14th 2023

Annual Incidence of Dementia in US Will Double by 2060, Reaching 1 Million Cases

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Rebekah Bernard, MD, a family physician and national speaker on physician wellness.

January 15th 2025

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

Annual incidence of dementia will double in White adults and triple among Black adults. The updated estimates place the lifetime risk of developing dementia after age 55 at 42%.

September 29th 2022

The FDA Accepts Eisai BLA for Lecanemab Subcutaneous Maintenance Dosing in Adults with Alzheimer Disease

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.

New Long-Term Data Suggest Continued Blarcamesine Efficacy in Alzheimer Disease Up to 4 Years

Weekly SC injection of lecanemab is expected to maintain clinical and biomarker benefits reached during the IV initiation phase. The PDUFA date is Aug 31, 2025.

Novel Tool Predicts Onset Age of Cognitive Impairment and Alzheimer Dementia

Blarcamesine significantly slowed progression of both cognitive and functional decline, with treatment initiated earlier in disease process more effective than that initiated later.

Related Content

January 16th 2025

Distress Signals: How to Help a Clinician Colleague in Need

The Florey Dementia Index showed robustness across different cohorts but more testing is needed, researchers reported.

February 14th 2023

Annual Incidence of Dementia in US Will Double by 2060, Reaching 1 Million Cases

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Rebekah Bernard, MD, a family physician and national speaker on physician wellness.

January 15th 2025

Primary Viewpoints Episode 19: Mobile Health Technology for Chronic Pain Management

Annual incidence of dementia will double in White adults and triple among Black adults. The updated estimates place the lifetime risk of developing dementia after age 55 at 42%.

September 29th 2022

The FDA Accepts Eisai BLA for Lecanemab Subcutaneous Maintenance Dosing in Adults with Alzheimer Disease

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.

New Long-Term Data Suggest Continued Blarcamesine Efficacy in Alzheimer Disease Up to 4 Years

Weekly SC injection of lecanemab is expected to maintain clinical and biomarker benefits reached during the IV initiation phase. The PDUFA date is Aug 31, 2025.